Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysis
Xinrong Zhang(Tianjin Medical University), Vincent Wai‐Sun Wong(Chinese University of Hong Kong), Henry Lik-Yuen Chan(Union Hospital), Jimmy Che‐To Lai(Chinese University of Hong Kong), Lilian Yan Liang(Chinese University of Hong Kong), Alice P.S. Kong(Chinese University of Hong Kong), Vicki Wing‐Ki Hui(Chinese University of Hong Kong), Grace Lai‐Hung Wong(Chinese University of Hong Kong), Guanlin Li(Chinese University of Hong Kong), Huapeng Lin(Chinese University of Hong Kong), Terry Cheuk‐Fung Yip(Chinese University of Hong Kong), Yee‐Kit Tse(Chinese University of Hong Kong), Stephen L. Chan(Chinese University of Hong Kong)
Cited by 29
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k